CLDN10 is highly expressed in osteosarcoma cells compared with fetal osteoblast cells, and CLDN10 overexpression in osteosarcoma cells enhances the JAK1/STAT1 signaling pathway to significantly promote proliferation and motility (51). Here, STAT1 is linked to osteosarcoma.